Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Latest Articles

  • Open Access
    Oleuropein Induces Cytotoxicity and Peroxiredoxin Over-expression in MCF-7 Human Breast Cancer Cells
    KATHERINE JUNKINS, MARGARET RODGERS and SHELLEY A. PHELAN
    Anticancer Research October 2023, 43 (10) 4333-4339; DOI: https://doi.org/10.21873/anticanres.16628
  • You have access
    Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)
    TOMOHIRO TAMURA, TAKESHI NUMATA, HIDETOSHI YANAI, RYOTA NAKAMURA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, SHINICHIRO OKAUCHI, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, HIROAKI SATOH, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, TAKEO ENDO, TORU SAKAMOTO and NOBUYUKI HIZAWA
    Anticancer Research October 2023, 43 (10) 4583-4591; DOI: https://doi.org/10.21873/anticanres.16652
  • Open Access
    Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expression
    SUHO PARK, YUNJOO CHO and HYUN-SOO KIM
    Anticancer Research October 2023, 43 (10) 4559-4571; DOI: https://doi.org/10.21873/anticanres.16650
  • Open Access
    Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
    KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, NAOKI SHIBATA, AZUSA SOEJIMA, TAKAHITO SUGISAKI, YUKA MORI, HISANORI SHIMIZU, MAYU YUNOKAWA, HIROYUKI KANAO and MASAKAZU YAMAGUCHI
    Anticancer Research October 2023, 43 (10) 4533-4541; DOI: https://doi.org/10.21873/anticanres.16647
  • You have access
    Role of Positive Biopsy Core Ratio in Prostate Cancer Patients
    HIROSHI KANO, KOUJI IZUMI, RYUNOSUKE NAKAGAWA, REN TORIUMI, SHUHEI AOYAMA, TAIKI KAMIJIMA, TAKAFUMI SHIMADA, RENATO NAITO, SUGURU KADOMOTO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
    Anticancer Research October 2023, 43 (10) 4619-4626; DOI: https://doi.org/10.21873/anticanres.16656
  • You have access
    A Novel Filtration Membrane for Clustered Circulating Tumor Cell Extraction: A Prospective Feasibility Study
    NORIYOSHI SAWABATA, KOHEI MORITA, SHIGENOBU TATSUMI, TOMOMI FUJII, TAKESHI NISHIKAWA, TAKESHI KAWAGUCHI, TORU ARAKANE, YOSHIAKI TOMINAGA, HIROKAZU SAKAGUCHI, TARO KOBAYASHI, SHIGETO HONTSU, YOSHIFUMI YAMAMOTO, NOBUHIRO FUJIOKA, NORIKO OUJI-SAGESHIMA, TOSHIHIRO ITO and CHIHO OHBAYASHI
    Anticancer Research October 2023, 43 (10) 4683-4690; DOI: https://doi.org/10.21873/anticanres.16664
  • Open Access
    Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma – A Single Center Analysis
    NAEMI GLASER, ANNE PETZOLD, ANJA WESSELY, MATTHIAS D. KAUFMANN, ELIAS A.T. KOCH, HARALD KNORR, CAROLINE VOSKENS, MARKUS V. HEPPT, CAROLA BERKING and MICHAEL ERDMANN
    Anticancer Research October 2023, 43 (10) 4525-4532; DOI: https://doi.org/10.21873/anticanres.16646
  • Open Access
    Circulating Tumor Cells and Tumor Progression, Metastasis, and Poor Prognosis in Patients With Neuroblastoma
    MASATO KOJIMA and EISO HIYAMA
    Anticancer Research October 2023, 43 (10) 4327-4331; DOI: https://doi.org/10.21873/anticanres.16627
  • Open Access
    Abstracts of the 33rd Annual Meeting of the Italian Society of Uro-Oncology (SIUrO)
    Anticancer Research October 2023, 43 (10) 4747-4778; DOI: https://doi.org/10.21873/anticanres.16672
  • Open Access
    Retraction
    Anticancer Research October 2023, 43 (10) 4780; DOI: https://doi.org/10.21873/anticanres.16674

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 1638
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire